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Pedobarography as a clinical tool in
the management of diabetic feet in
New Zealand: a feasibility study
Jason K. Gurney1* , Uwe G. Kersting2, Dieter Rosenbaum3, Ajith Dissanayake4, Steve York5, Roger Grech4,
Anthony Ng4, Bobbie Milne4, James Stanley1 and Diana Sarfati1
Abstract
Background: The peripheral complications of diabetes mellitus remain a significant risk to lower-limb morbidity. In
New Zealand, risk of diabetes, comorbidity and lower-limb amputation are highly-differential between demographic
groups, particularly ethnicity. There is growing and convincing evidence that the use of pedobarography – or
plantar pressure measurement – can usefully inform diabetic foot care, particularly with respect to the prevention
of re-ulceration among high-risk patients.
Methods: For the current feasibility study, we embedded pedobarographic measurements into three unique
diabetic foot clinic settings in the New Zealand context, and collected pedobarographic data from n = 38 patients
with diabetes using a platform-based (Novel Emed) and/or in-shoe-based system (Novel Pedar). Our aim was to
assess the feasibility of incorporating pedobarographic testing into the clinical care of diabetic feet in New Zealand.
Results and Conclusions: We observed a high response rate and positive self-reported experience from
participants. As part of our engagement with participants, we observed a high degree of lower-limb morbidity,
including current ulceration and chronic foot deformities. The median time for pedobarographic testing (including
study introduction and consenting) was 25 min. Despite working with a high-risk population, there were no
adverse events in this study. In terms of application of pedobarography as a clinical tool in the New Zealand
context, the current feasibility study leads us to believe that there are two avenues that deserve further
investigation: a) the use of pedobarography to inform the design and effectiveness of offloading devices among
high-risk diabetic patients; and b) the use of pedobarography as a means to increase offloading footwear and/or
orthoses compliance among high-risk diabetic patients. Both of these objectives deserve further examination in
New Zealand via clinical trial.
Keywords: Diabetes, Pedobarography, Lower-limb complications, Ulceration, Plantar pressure
Background
Diabetes mellitus is a metabolic dysfunction charac-
terised by high concentrations of glucose within blood
(termed hyperglycaemia), which is caused by deficits in
insulin production and activity [1, 2] and/or cellular re-
sistance to insulin [3]. One of the most common compli-
cations of diabetes is peripheral neuropathy [4], which
involves damage to and dysfunction of peripheral nerves –
starting at the extremities of the limbs, then progressing
towards the torso [5]. A loss of peripheral sensory
function – and thus pain signalling [6] – compounded by
autonomic and neuromuscular complications [7, 8] in-
creases the risk of foot ulceration due to trauma or repeti-
tive loading of the plantar surface of the foot [9]. If left
untreated, these ulcers can become infected – and due to
reduced healing capacity [10], infected wounds can be-
come gangrenous and lower-limb amputation may ultim-
ately be required [7].
Patients with diabetes are 15 times more likely to
require lower-limb amputation than people without
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diabetes [5, 11], and 15% of those with diabetes and per-
ipheral neuropathy will require foot amputation [12, 13].
The vast majority (80%) of lower-limb amputations
among patients with diabetes are preceded by a foot
ulcer [9]; thus, primary intervention to prevent foot ul-
ceration among these patients – and secondary interven-
tion that assists in expedient healing of current ulcers –
is a highly-desirable goal for both the patient and health
care services.
Pressures beneath the plantar surface of the foot are
increased in the diabetic foot compared to healthy popu-
lations [14–17]. These increases in pressure are the re-
sult of a combination of morphological, muscular and
sensory abnormalities [7, 14, 18–21]. For example,
‘clawing’ of the toes is common among the diabetic
population [7], as is the deformity known as hallux
valgus [22, 23] which arises in one-third of all patients
with diabetes [24] due to weakening of intrinsic foot
musculature in the hallux region [25]. These foot and
toe deformities ultimately lead to localised increases in
plantar pressure, particularly at the metatarsal heads
[14]. Crucially, there is a high correlation between ele-
vated plantar pressure and foot ulceration [15, 26–29].
Plantar pressure and the dynamic structure of the
foot can be measured using a technique called
pedobarography – in which measurements of plantar
pressure are taken during walking, either via insole-
based [30] or platform-based systems [31]. Pedobaro-
graphic measurements provide a clinically-relevant
quantification of the stress that small areas of the
plantar surface are experiencing during barefoot or
shod walking, and also enable identification of any
abnormalities in dynamic foot structure that may be
causing these elevated plantar pressures [21].
Evidence to date suggests that the use of pedobarogra-
phy can have a profound impact on the prevention of ul-
ceration among patients with diabetes. In 2013, Bus et
al. [32] observed that among patients with a recently-
healed plantar ulcer who had high adherence to their
treatment, the use of in-shoe pressure measurements to
guide footwear customisation substantially reduced the
risk of ulcer reoccurrence compared to those who re-
ceived footwear that was not modified based on this data
(re-ulceration odds ratio: 0.38, 95% CI 0.15–0.99) [32].
In 2014, Ulbrecht et al. [33] conducted a randomised
controlled trial (RCT) within a diabetic foot clinic set-
ting, randomly assigning patients with recently-healed
ulcers into two treatment groups: those for whom plan-
tar pressure measurement was used to inform the design
and construction of orthoses that offload the site of the
ulcer (intervention group), and those who received
standard orthoses (control group). The premise of the
intervention was that orthoses designed with plantar
pressure information would result in better offloading of
high-pressure areas of the foot [34]. Astonishingly, the
authors observed that the rate of re-ulceration among
patients in the control group was three-and-a-half-times
higher than the intervention group (re-ulceration pro-
portions: intervention group 9.1%, control group 25.0%;
adjusted hazard ratio [HR]: 3.4, 95% CI 1.3–8.7). This
evidence suggests that there is an opportunity for pedo-
barography to customise treatment plans and substan-
tially improve outcomes among high-risk patients with
diabetes [33].
Pedobarography as a clinical tool is not just limited to
assisting construction of offloading orthoses: it is pos-
sible that screening patients with diabetes for the pres-
ence of high plantar pressures can prevent ulceration by
prompting clinical attention toward areas of high pres-
sure that otherwise may have gone unnoticed (including
initiating efficacious treatment, such as debridement).
There is some evidence that pedobarography has a rela-
tively high degree of specificity (and a moderate degree
of sensitivity) in identifying those at risk of developing a
foot ulcer [35].
There are several other potential pathways by which
pedobarography may reduce risk of diabetic foot ulcer-
ation: for example, it is possible that pedobarography
may provide an effective source of biofeedback for
patients – whereby patients are provided with informa-
tion regarding peak pressures beneath their feet, and
then alter potentially-harmful behaviour as a result (e.g.
wearing adequate footwear) [36]. Our understanding of
the potential impact of pedobarography as a biofeedback
tool is still in its infancy.
Diabetes in the New Zealand context
Diabetes is a common chronic condition in New
Zealand – with more than 6% (or >220,000 people) of
the adult population diagnosed with the disease [37].
The prevalence of diabetes is not evenly distributed
across the population [38, 39]: while the majority
European population has a diabetes prevalence of 5%, it
is estimated that more than 7% of indigenous Māori and
13% of the Pacific Island population are affected by this
disease [37]. Māori not only carry an inequitable burden
of diabetes, but are also more likely to experience other
serious comorbidity (such as cardiovascular [40] and
renal disease [41]) – and have rates of lower-limb ampu-
tation that are 84% higher than those experienced by
non-Māori/non-Pacific/non-Asian patients with diabetes
(adjusted HR: 1.84, 95% CI 1.54–2.19) [42]. Pacific New
Zealanders with diabetes appear no more likely to
require lower-limb amputation than New Zealand
Europeans [42]. The reasons for this disparity in ampu-
tation risk remain obscure.
In summary, there is a burgeoning body of evidence
that suggests pedobarography can play a role in
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preventing serious limb- (if not life-) threatening compli-
cations among patients with diabetes. However, the effi-
cacy of such an intervention remains scantily explored
in clinical trials, and is entirely untested in the New
Zealand context. The aim of the feasibility study de-
scribed here was to begin to address this information
gap by answering the following questions:
 What is the response rate among patients invited to
take part in pedobarographic testing?
 To what extent does the additional testing interrupt
normal clinic time?
 What is the experience of patients who take part in
pedobarographic testing?
 What applications of pedobarographic testing are
most useful to those clinicians in charge of diabetic
foot care?
 What aspects of pedobarography could feasibly be
tested in a clinical trial?
 What unique issues exist in NZ that impact the
usefulness of pedobarography as a tool in the care of
the diabetic foot, and/or will need to be taken into
consideration during a full clinical trial? For example,
what type of footwear (closed/non-closed) do patients
routinely wear to clinical appointments?
The current manuscript describes our observations
with respect to these questions.
Methods
Data collection setting
Pedobarographic testing was offered to patients attend-
ing outpatient diabetic foot clinics in three separate lo-
cations in the northern part of New Zealand. The
clinics were: Manukau Superclinic (South Auckland),
Whangarei Hospital High-Risk Foot Clinic (Whangarei),
and the Bay of Islands Hospital High-Risk Foot Clinic
(Kawakawa). The South Auckland and Whangarei clinics
are located in metropolitan areas, while the Kawakawa
clinic is located in a rural area. Data collection occurred
over eight separate clinic days between 9th November to
25th November 2016.
The diabetic foot clinics were a mixture of a) high-risk
clinics treating patients with current or healing ulcers
(three clinic days), b) moderate-risk clinics treating pa-
tients requiring foot assessment but without a current or
healing ulcer (three clinic days), and c) general diabetes
clinics at which patients receive a general assessment of
their diabetic health (two clinic days).
Participants
Potential participants were patients with Type-1 or
Type-2 diabetes who were attending clinics as part of
their normal diabetes care, referred by their diabetes
clinicians. Only patients who were able to walk without
pain were invited in to the study (e.g. those in wheel-
chairs were not included). The total number of patients
who were invited in to the study, as well as the number
of patients who declined (and the reason given for de-
clining), was derived from self-report from the referring
clinicians.
A total of 48 patients were invited to participate in the
study by referring clinicians, of whom 39 agreed
(response rate: 81% of those invited). The most common
reason for declining to participate in the study was time
pressure (n = 7; 77% of those who declined). One patient
began pedobarographic testing but stopped due to walk-
ing difficulty, and thus was excluded from further ana-
lysis. Therefore, the final study group included 38
participants.
Those who agreed to participate in the study were
taken to meet the pedobarography team (JG, UK,
DR), at which point the clinician provided the study
team with the clinical characteristics of the patient,
including the presence of peripheral neuropathy, foot
deformity, previous or current ulceration, amputa-
tion(s) and other relevant lower-limb complications.
The clinician also stated what information they hoped
to gain from the pedobarographic measurement. The
patient was taken by a team member (JG) to a quiet
area to discuss what was involved in participation,
and to gain written informed consent. Once the con-
sent process was completed, pedobarographic mea-
surements began.
Demographic data collection
Participant age in years was provided by the referring
clinician, as derived from clinical records. Participant
ethnicity was self-identified using the ethnicity categori-
sations used in the 2013 New Zealand Census, in which
a participant can choose multiple ethnic affiliations. Eth-
nicity data were aggregated into New Zealand European,
Māori, Pacific Island and non-New Zealand European/
Māori/Pacific for reporting.
Pedobarography measurements
Pedobarographic measurements were performed with ei-
ther a platform-based system (Emed AT, 2 sensors/cm2,
Novel GmbH, Munich, Germany) and/or an insole-
based system (Pedar X, Novel, Munich Germany). A de-
cision whether to use the platform-based system, in-
shoe based system or both was made in consultation
with the clinician. This decision was made based on
what information the clinician hoped to gain from the
pedobarographic measurement; for example, if the clin-
ician was hoping to ascertain whether a recently-
introduced offloading device was actually reducing loads
around a site of a current ulceration, the in-shoe system
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was used. In many cases, the clinician was interested in
comparing conditions (hereafter termed ‘multiple
conditions’); for example, in-shoe pressures using a
standard orthotic insert compared to a customised orth-
otic insert, or barefoot pressures before and after plantar
debridement. If only one condition was of interest (e.g.
only barefoot pressure), this was termed ‘single condi-
tion’. The system-specific method of data collection is
described below for each system type.
Data were collected within the Novel Emed and/or
Novel Pedar data collection software. For the platform-
based system, participants were instructed to walk bare-
foot over an 8 m foam runway, with the Emed platform
located in the middle of the runway. Participants were
instructed to walk at normal pace and to not aim for the
platform as they walked. A minimum of three steps were
taken before and after contacting the platform [43]. Five
trials were collected per foot (one trial = one foot) for
each participant [44–46], although for some participants
only three trials per foot could be practically collected,
primarily due to participant fatigue and difficulty in
striking the platform.
For the insole-based system, participants were fitted
with the correct insoles for their shoe size (most com-
monly size EU 42 insole). Footwear was not standardised
across participants; rather, participants wore their usual
footwear. For some participants, testing was conducted
using two different kinds of footwear (e.g. dress shoes
and sports shoes). Footwear type was categorised by the
study investigators as either: cushioned sports shoes,
surgical/orthopaedic shoes, work boots, or casual/non-
cushioned sneakers. In order to conduct the in-shoe
testing, participants wore a waist belt which contained a
wireless telemetry unit and a battery. Once fitted with
the insoles and waist belt, participants were instructed
to walk a distance of approximately 15 m, before turning
and returning to the place where they started. Insole
pressure data were collected during both of these walks,
ensuring data for at least 20 steps were collected from
each participant.
The time taken (in minutes) to conduct the data col-
lection component of the study was measured from the
time that the patient arrived at the pedobarography sta-
tion to time of their departure, including study explan-
ation and consent process.
Post-pedobarography discussion with participants
At the conclusion of platform and/or insole pressure
measurements, the collected trials were averaged within
the relevant Novel software before being presented to
the participant. The mean peak pressure (MPP) for each
foot was used as the primary outcome for the purposes
of data interpretation. Members of the study team with
expertise in pedobarography (UK, DR) interpreted the
collected trials for the participant, and answered any
questions that the participant asked.
Following data interpretation, the participant was asked
a small number of pre-set questions (specifically designed
for this study) regarding their experience during data col-
lection. These questions included a) whether the partici-
pant enjoyed their experience; b) whether the participant
would participate again if the test was available as part of
their regular clinical care; c) whether there were aspects of
the test that were difficult or annoying; and d) whether
the information received regarding their plantar pressures
was useful (and if so, how). Information was also gathered
regarding the type of footwear worn to the clinical ap-
pointment, and participants were asked what footwear
they most commonly wore.
Data management and analysis
Averaged pedobarography data were not formally ana-
lysed in terms of quantitative factors such as peak pres-
sure and maximum force; rather, they were used to
generate images for the purposes of presentation and in-
terpretation with participants and clinicians. They were
also used to provide the case study examples described
later in this manuscript.
Self-report data were collected on paper by the pedo-
barography team, and transferred to Microsoft Excel
2010. Crude descriptive results (including proportions,
%) were generated for relevant data.
Ethical approval for this study was sought and received
from the University of Otago Human Ethics Committee
(reference #: HE16/007), as well as local authorisation
from the two District Health Boards within which the
study was operating (Northland and Counties-Manukau).
Results
Participant characteristics
The median age of the 38 participants was 57 years
(interquartile range [IQR]: 51.5–65.5 years). Participants
were most commonly Māori (n = 15; 39% of partici-
pants), followed by New Zealand European (n = 9; 24%),
Pacific Island (n = 8; 21%) and non-Māori/Pacific/
European (n = 6; 16%).
In terms of the clinic type that participants were re-
ferred from, a total of 21 were referred from high-risk/
ulcer foot clinics (55% of participants), with 10 (26%) re-
ferred from moderate-risk/non-ulcer foot clinics and 7
(18%) referred from low-risk/general diabetes clinics.
Clinical presentation and pedobarography application
Table 1 shows the major lower-limb complications expe-
rienced by patients as reported to the study team at the
time of referral, grouped according to the type of clinic
that the patient was referred from. The most common
complications included current ulceration (n = 9; 24% of
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Table 1 Patient-level listing of existing lower-limb complications and clinical application of pedobarographic measurements,
stratified by clinic type
Pedobarography
type
Application category
Clinic type Patient # Lower-limb complications Clinical application of pedobarography Barefoot In-Shoe Single
condition
Multi- condition
High risk/Ulcer 1 Current ulcer beneath Left 3rd and
4th metatarsal heads
Assess barefoot plantar loading under
healing ulcer site
● ●
2 Not documented Assess in-shoe plantar loading with
orthopaedic shoe and custom insoles
● ●
3 Functional leg length discrepancy,
has Left heel raise in shoes
Assess plantar loading, particularly
around heel raise
● ●
4 Current ulcer beneath Right forefoot Compare in-shoe plantar loading
between work boots and sports shoes,
with offloading insole in both
● ●
5 Current ulcers on medial aspects
of Left and Right hallux
Assess barefoot medial plantar loading
and centre of pressure line
● ●
6 Peripheral neuropathy Assess barefoot loading, particularly
under 1st and 5th metatarsal heads
● ●
7 Not documented Compare in-shoe plantar loading
between no insole and custom
orthotic insole
● ●
8 Peripheral neuropathy,
severe burns under feet
General assessment of barefoot
pressures, plus compare to in-shoe
pressures to show benefit of orthotic
shoe and insole
● ● ●
9 Left hallux amputation Assessment of in-shoe loading with
orthotic footwear, with and without
walking frame
● ●
10 Left 3rd toe amputation,
Right 2nd toe amputation
Assessment of barefoot pressures,
particularly around areas of digit
amputation
● ●
11 Current ulcer under Left forefoot;
Left 2nd-4th toe amputation
Assessment of plantar offloading
within surgical shoes with custom
insoles
● ●
12 Right foot 3rd-5th toe amputation;
blister on side of Right 2nd toe
Assessment of barefoot pressures,
particularly around areas of digit
amputation
● ●
13 Current ulcer under Right 1st
metatarsal head
Compare in-shoes loading between
Pedor (surgical offloading shoe) and
‘Crocs’ non-closed shoes
● ●
14 Current ulcer under Right heel Assess in-shoe loading, particularly
around Right heel wound
● ●
15 Right hip osteoarthritis, Right knee
brace, walks with stroller
Assess in-shoe loading within Pedor
orthopaedic shoes
● ●
16 Left 2nd toe amputation,
Left 3rd toe deformity
Assess barefoot loading, particularly
around area of amputation
● ●
17 Current ulcers on medial side of
Left and Right hallux
Assess barefoot loading, particularly
around Left and Right hallux
● ●
18 Current ulcer under medial aspect
of Right hallux
Assess barefoot loading under healing
ulcer site
● ●
19 Peripheral neuropathy General assessment of barefoot loading ● ●
20 Acute Charcot foot Assess in-shoe loading with shoes and
orthotic insoles
● ●
21 Current ulcer under Right hallux,
painful and swollen Left foot
Assess barefoot loading under healing
ulcer site
● ●
Mod risk/Non-ulcer 22 Both knees partial amputation
following car accident
Assess loading patterns with and
without custom insoles
● ●
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all participants) and partial foot amputation (n = 5;
13%), although the type and location of lower-limb com-
plications was variable across participants.
Table 1 also shows the primary clinical application of
the pedobarographic testing for each patient, as dis-
cussed with the clinician at the time of referral. The
most common applications included assessments of
loading around current ulcer sites (n = 9; 24% of all par-
ticipants), and more general/non-specific assessments of
barefoot loading (n = 9; 24%).
Pedobarographic assessments involved either barefoot
assessments with the Novel Emed system (n = 22; 58%
of all participants; Table 1), in-shoe assessments with the
Novel Pedar system (n = 16; 34%), or a combination of
the two (n = 3; 8%). Based on the primary clinical appli-
cations for which the pedobarographic testing was used,
we were able to categorise patients according to whether
their assessment involved a single condition (n = 28;
74%) or multiple conditions (n = 10; 26%). For example,
the participant for whom barefoot assessments were per-
formed both before and after callous debridement was
categorised as undergoing multiple conditions.
The median time taken to conduct the pedobaro-
graphic testing was 25 min (IQR = 20–30 min), includ-
ing the time taken to explain the study and gain
informed consent. The time taken to conduct the testing
did not meaningfully differ depending on whether bare-
foot measurements (n = 22; median = 25 mins, IQR = 20–
30 min), in-shoe measurements (n = 13; 25 mins,
IQR = 20–34 min) or both (n = 3; 20 mins, IQR = 15–
25 min) were conducted, nor whether a single condition
(n = 28; 25 min, IQR = 20–30 min) or multiple condi-
tions (n = 10; 21 min, IQR = 20–30 min) were con-
ducted. Numerous observations of potential clinical
importance were made during pedobarographic assess-
ments, and we have detailed three examples in Fig. 1.
Table 1 Patient-level listing of existing lower-limb complications and clinical application of pedobarographic measurements,
stratified by clinic type (Continued)
23 Severely enlarged Left and Right
hallux (congenital deformity)
Assess barefoot loading,
particularly hallux region
● ●
24 Charcot deformity Compare barefoot and in-shoe
loading, show patient benefit of
wearing offloading footwear
● ● ●
25 None General assessment of barefoot
loading
● ●
26 Gout Compare old orthotic insoles
with new custom orthotic insole
● ●
27 Flat feet General assessment of barefoot
loading
● ●
28 Severe recurrent callous under
metatarsal heads
Compare barefoot loading pre-
and post-callous debridement
● ●
29 Charcot deformity; former ulcers
under Right forefoot and hallux
Assess in-shoe loading under
former ulcer sites and Charcot
deformity
● ●
30 Veruca on medial aspect of
Right heel
Compare barefoot and in-shoe
loading, show patient benefit of
wearing offloading footwear
● ● ●
31 Left midfoot deformity Assess barefoot loading,
particularly around Left midfoot
deformity
● ●
Low risk/General 32 Peripheral neuropathy General assessment of barefoot
loading
● ●
33 None General assessment of barefoot
loading
● ●
34 None General assessment of barefoot
loading
● ●
35 Arthritic pain in feet General assessment of barefoot
loading
● ●
36 None General assessment of barefoot
loading
● ●
37 Right foot pain under forefoot,
callus under Right metatarsal heads
General assessment of barefoot
loading
● ●
38 Pain under Left and Right Forefoot Assess barefoot loading under
painful Left and Right forefoot
● ●
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Fig. 1 (See legend on next page.)
Gurney et al. Journal of Foot and Ankle Research  (2017) 10:24 Page 7 of 13
Participant experience
Table 2 shows data relating to the participant’s experi-
ence of the pedobarography assessment. When asked
after the pedobarography assessment and data interpret-
ation if they had enjoyed their experience, all partici-
pants said yes (n = 38; 100%). When asked if they found
any aspects of the study annoying or frustrating, most
participants said no (n = 30; 79%). The reasons given by
the n = 5 (13%) participants who said they found any as-
pect annoying or frustrating included: awkwardness/em-
barrassment walking in an open area, experience of back
pain during walking, tiredness from walking too much,
the time taken to participate and difficulty walking in a
straight line. When asked if they would take part in ped-
obarographic assessments if they were offered to them
in the future, the vast majority of participants said yes
(n = 31; 82%). When asked if they had found the infor-
mation given to them following their assessment useful,
most participants said yes (n = 34; 89%). The reasons
given for why these participants found the information
useful are provided in the Additional Material (Add-
itional file 1).
Footwear behaviour
The footwear worn by participants to their clinical ap-
pointment is shown in Table 3. Footwear varied consid-
erably and was patterned by clinic type. Across the total
group, the majority of participants wore closed footwear
to their appointment (n = 23; 71% of all participants).
The most common closed footwear type worn by partic-
ipants was surgical/orthopaedic footwear (n = 11; 29%).
When examining footwear behaviour by clinic type,
those attending high-risk foot clinics were most likely to
wear closed footwear (n = 16; 76% of high-risk partici-
pants), followed by those attending moderate-risk clinics
(n = 7; 70% of moderate-risk participants) and then
those attending low-risk clinics (n = 4; 57% of low-risk
participants). The most common closed footwear worn
by those attending high-risk foot clinics were surgical/
orthopaedic footwear (n = 10; 48%).
Discussion
The aim of this study was to assess the feasibility of in-
corporating pedobarographic testing into the clinical
care of diabetic feet in New Zealand. Specifically, we
aimed to assess a) the response rate among patients in-
vited to take part in pedobarographic testing; b) the ex-
tent to which additional testing interrupts normal clinic
time; c) the experience of patients who took part in ped-
obarographic testing; d) the applications of the pedo-
barographic testing that were most useful to those
clinicians in charge of diabetic foot care; and finally e)
which aspects of the pedobarographic intervention could
feasibly be tested in a clinical trial.
Response rate
In terms of response rate, we observed that the vast ma-
jority of those patients invited to participate agreed to
do so (81%). The high response rate is perhaps unsur-
prising, for two reasons: firstly, the study was introduced
to the patient by their clinician – most of whom were
co-investigators on the study. Secondly, participation in
(See figure on previous page.)
Fig. 1 Examples of clinical applications of pedobarographic measurements; a barefoot pressure measurements from Patient #12, showing
extreme midfoot loading under the Right foot indicative of an undiagnosed Charcot deformity; b barefoot pressure measurements from Patient
#28, showing plantar loading beneath metatarsal heads before (left) and after (right) callous debridement; c barefoot and in-shoe measurements
from Patient #30, showing extreme barefoot loading (left foot used as exemplar) that was significantly attenuated by the introduction of
cushioned footwear and a custom insert with forefoot padding, as measured with the in-shoe system (right)
Table 2 Self-reported patient experience of pedobarographic
testing
Measure of patient experience Patients
n %
Time taken to perform pedobarography (minutes)a
Median (IQR) 25 (20–30)
Range 15–40
Post-Testing Questions to Participants
Did the patient enjoy the test?
Yes 38 100%
No 0 0%
Don’t know 0 0%
Were there any parts that were annoying or frustrating?
Yes 5 13%
No 30 79%
Don’t know 3 8%
If this test was offered to you again, would you do it?
Yes 31 82%
No 0 0%
Don’t know 7 18%
Did you find the information useful?b
Yes 34 89%
No 0 0%
Don’t know 3 8%
aTime from patient arriving at pedobarography station to time of their
departure, including study explanation and consent process
bQuestion asked following explanation and interpretation of pedobarography
observations with biomechanics experts (DR, UK)
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the study did not require participants to travel elsewhere
to take part or return for later assessment, since partici-
pation took place directly following the patient’s usual
clinical appointment.
Disruption to clinics
With regards to disruption to normal clinic time, all but
one of the participants underwent pedobarographic test-
ing after their normal clinical appointment, and thus the
normal clinical appointment was not interrupted. We
observed that the pedobarography test was relatively
quick to perform. Even when including those partici-
pants for whom multiple conditions were tested, the me-
dian duration of the test was 25 min – including the
time taken to explain the test to participants and gain
informed consent. The participants were overwhelmingly
positive about their experience during the study – with
all stating that they enjoyed their experience, and most
(89%) stating that they found the information they re-
ceived at the conclusion of the test useful.
Patient complexity
In general, most of the patients referred into the study
were clinically complex. Most suffered multiple lower-
limb complications (some unrelated to their diabetes),
and many had already undergone partial foot amputa-
tion. While all but one patient was able to complete the
walking required to collect the pedobarographic data,
several patients had limited mobility – in which case the
in-shoe system was preferred, since less walking is re-
quired with this system in order to gain sufficient data.
Only two of the patients who participated in the study
usually walked with either a cane or a walking frame, al-
though both were able to comfortably walk without this
support. The use of a cane or walking frame has ramifi-
cations in terms of plantar loading, in that the offloading
achieved via the use of these devices is likely to reduce
loading under the feet. While it is important to be aware
of this likelihood, measurements taken from this
population are still meaningful – in that they still repre-
sent the usual plantar loads experienced by that patient
while walking (assuming the device is used during the
majority of the patient’s ambulation). It is also import-
ant to note that relative comparisons between condi-
tions (e.g. custom orthoses compared to standard
insole) would also be unaffected by the use of mobility
support.
Adverse events
Despite working with a high-risk population, there
were no adverse events in this study – an observation
which is in-keeping with the low-risk nature of the
medical device(s) used during the study. The greatest
negative impact on patients was likely the time taken
to participate (although only one of the five patients
who stated that they found some aspect of the study
annoying or frustrating identified the time taken to
collect data as their key annoyance/frustration). As a
means of combatting this, it would have been useful
to conduct pedobarographic testing during a separate
appointment, rather than as an optional addition to
an existing appointment. This would have had the
added benefit of warning participants in advance
about the need to bring items such as their normal
footwear and offloading devices, and also assist the
research team in preparing for a patient’s arrival –
which, on occasion, was difficult when patients were
being referred from several clinics simultaneously.
However, it was not pragmatically possible to book
appointments for patients ahead of time for the
current feasibility study.
Clinical application of pedobarography during the study
The most common reason that patients were referred
into the study by clinicians was to assess plantar loading
around a site of a current or previous ulcer, with nearly
a quarter (24%) of all participants referred for this rea-
son. In most instances, we were able to observe the
Table 3 Footwear-related behaviour for total sample and by clinic type
Patients, by clinic type
Footwear behaviour Total patients High risk/ulcer Mod. risk/non-ulcer Low risk/general
n % n % n % n %
Patient wearing closed footwear to clinic 27 71% 16 76% 7 70% 4 57%
Cushioned sports shoes 9 24% 4 19% 4 40% 1 14%
Surgical/Orthopaedic shoesa 11 29% 10 48% 1 10% 0 0%
Work boots 3 8% 1 5% 1 10% 1 14%
Casual/non-cushioned sneakers 4 11% 1 5% 1 10% 2 29%
Patient wearing non-closed footwear to clinicb 11 29% 5 24% 3 30% 3 43%
aSurgical/orthopaedic shoes were primarily Pedor Stretch diabetic orthopaedic shoes
bnon-Closed footwear included flip-flops (n = 5), sandals, (n = 1), slides (n = 2), ‘Crocs’-style shoes (n = 2) and Mary Janes (n = 1)
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degree to which offloading had been achieved with cus-
tom orthoses (Table 1). This information was fed-back
to the patients and, where possible, also to the referring
clinician. Our ability to compare in-shoe offloading
interventions – interventions generally provided with lit-
tle idea of the degree to which offloading is actually be-
ing achieved – was the most popularly-applied example
of a clear and feasible means by which pedobarography
could be integrated into diabetic foot care in New
Zealand.
The value of general foot screening among those pa-
tients referred from general diabetes clinics was less
clear. Seven of those patients who participated in the
current study (18% of participants) were referred by ei-
ther diabetes nurse specialists or dieticians, and most of
these patients had minor (if any) lower-limb complica-
tions. Because of this, participation was unlikely to result
in meaningful information that might affect the foot care
of these patients in the short- to medium-term. How-
ever, all (100%) of these participants still reported that
they found the information useful; and when asked what
they found most useful, several stated that the test had
made them ‘more aware’ of their feet (Additional file 1).
We may cautiously extrapolate from this observation
that the test may have positively impacted the foot-
related health of the patient in the medium- to long-
term, by providing them with some education about the
importance of plantar pressure, the choice of appropriate
footwear and taking care of their feet; however, this is
purely speculative. Given the absence of evidence that
early intervention with pedobarography improves dia-
betic foot outcomes among low-risk patients, further
work is required to understand the possible benefits
(and harms) of pedobarographic measurements in this
population.
Application of pedobarography in other international
contexts
To date, the application of pedobarography to diabetic
foot care has fallen into two categories: 1) as a means of
predicting the risk of ulceration [35, 47]; and 2) as a
means of informing the construction of offloading orth-
oses [32–34, 48, 49]. With respect to the former, Pham
et al. [35] compared the value of multiple clinical
markers (including peripheral sensation, vibration per-
ception, a neuropathy disability score, and barefoot peak
plantar pressure) for predicting whether a patient would
sustain a foot ulcer within a period of several years. The
authors observed only moderate sensitivity (59%) and
specificity (69%) when the test was used only by itself;
however, specificity improved somewhat (up to 78%)
when the plantar pressure data were combined with
the neuropathy disability score. Similarly, Lavery et al.
[47] investigated the usefulness of barefoot pressure
measurements as a means of predicting which of
the patients that presented to a diabetes outpatient
clinic would ulcerate. These authors also observed
only modest sensitivity and specificity when pedobar-
ography was used on its own as a predictive tool
[47]. However, as noted by Bus [50], the predictive
value of in-shoe pedobarographic measurements re-
mains unexplored. A key challenge to the viability of
using pedobarography as an ulcer-prediction tool is
the absence of a widely-used, validated threshold of
peak plantar pressure beyond which a patient is likely
to be at increased risk of ulceration.
While the predictive value of pedobarography in terms
of plantar ulceration remains uncertain, the value of this
tool in guiding clinicians to the effective management of
current (or previous) ulcers is more convincing. Owings
et al. [34] observed that insoles created with the support
of pedobarographic information resulted in a 32% and
21% reduction in peak pressure compared to two insoles
(respectively) that were independently constructed with-
out this information [34]. Ulbrecht et al. [33] observed
that patients for whom insole design was not guided by
barefoot pressure measurements were nearly three-and-
a-half-times more likely to sustain an ulcer compared to
a group of patients for whom this information was col-
lected (adjusted hazard ratio [HR]: 3.4, 95% CI 1.3–8.7)
[33]. Bus et al. [49] used in-shoe pedobarographic mea-
surements to optimise footwear modifications among
neuropathic diabetic patients, and successfully reduced
plantar pressure by nearly a third (30%) across the co-
hort using this information. In a separate study, Bus et
al. [32] observed that among patients with a recently-
healed plantar ulcer who had high adherence to their
treatment, the use of in-shoe pressure measurements to
guide the modification of custom footwear substantially
reduced the risk of ulcer reoccurrence compared to
those who received custom footwear that was not modi-
fied based on this data (re-ulceration rate: 26% pedobar-
ography group, 48% usual care group; odds ratio 0.38,
95% CI 0.15–0.99) [32].
When speaking about the role of pedobarography
in guiding the care of high-risk diabetic feet, Bus
[50] recently wrote: “This is a major innovation for
footwear prescription practice, which has traditionally
been more of an art than a science, where footwear
was designed and evaluated based on the expertise,
skills and experience of the prescribing physician and
shoe technician, and efficacy was judged by whether
a foot ulcer developed or not.” Based on the recent
evidence detailed above, and our own observations
made during this feasibility study, the efficacy of
pedobarography in the reduction of diabetic foot
morbidity in New Zealand deserves further examin-
ation via clinical trial.
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Observations regarding clinical trial development
In terms of a clinical trial development, the current study
leads us to believe that there are two (non-mutually exclu-
sive) avenues that deserve further investigation: a) the use
of pedobarography to inform the design and effectiveness
of offloading devices among high-risk diabetic patients, as
has been performed elsewhere (but not with a focus on
the specific needs in the New Zealand population); and b)
the use of pedobarography as a means to increase offload-
ing footwear and/or orthosis compliance among high-risk
diabetic patients (including patients with current ulcer-
ation). Both of these investigations may only require an
in-shoe pedobarography system, since this system can be
readily used to measure the effectiveness of interventions
in high-risk populations. There may be some benefit in
using barefoot measurements to assist with the creation of
custom insoles, as has been performed in the past [33, 34];
however, it is also possible that the in-shoe system may
provide the necessary information to assist with reduc-
tions in plantar loading [32, 49].
The current feasibility study taught us numerous les-
sons regarding the logistical operation of a full clinical
trial. For example, nearly all patients in the study under-
went pedobarographic testing at the conclusion of their
clinical appointment. As such, it was difficult to immedi-
ately inform foot care when the patient was not going to
return to the referring clinician after the pedobarography
test (commonly, the referring clinician had already
moved on to their next patient). A trial that formally
aimed to evaluate the usefulness of pedobarography in
informing diabetic foot care in New Zealand should con-
sider a) which pedobarographic information needs to be
collected from the patient (including condition compari-
son, such as custom insoles vs. standard insoles, or other
pressure-reducing interventions such as debridement
and hosiery); b) who needs this information (e.g. an
orthotist, if informing the design of offloading orthoses);
and c) when this person needs this information (e.g. im-
mediately so that an offloading intervention can be cus-
tomised before the patient leaves the clinic). Again,
collecting this information during a separate appoint-
ment (which could be immediately after the normal clin-
ical appointment) is appealing, since it would allow for
flexibility in terms of condition comparison and immedi-
ate feedback to relevant parties.
Footwear
The majority (71%) of patients wore at least some form
of closed footwear to their appointment, while 29% wore
non-closed footwear (such as flip-flops); however the
type of footwear worn to a clinical appointment is not
necessarily indicative of chronic footwear behaviour. For
example, it is feasible that patients are more likely to
wear the footwear that they believe will be viewed most
favourably by their podiatrist (in the case of those at-
tending foot clinics).
Data regarding footwear behaviour in New Zealand –
and, of particular relevance, how this behaviour is
patterned by demographic characteristics including
ethnicity – is scarce; however, some authors have sug-
gested that the wearing of non-closed footwear is com-
mon in New Zealand [51]. Given a) the importance of
offloading footwear and insert interventions, and b) the
possibility that cultural commonalities may reduce ad-
herence to closed footwear (particularly during the warm
summer months [52]), further prospective research is re-
quired around footwear compliance in this population –
since the efficacy of any offloading intervention among
high-risk diabetic patients is entirely contingent on ha-
bitual adherence [32].
Limitations
The accuracy of the response rate achieved in this study
relies on self-report from the referring clinicians, who
were asked to report to the research team when patients
declined to participate. It is feasible that, amidst a busy
clinical environment, some clinicians did not report
some declines – in which case, the high response rate
gained in the current feasibility study may be an exag-
geration. On the other hand, given that the main reason
patients gave for declining was time restriction (e.g.
needing to leave immediately following the appointment
to return to their job), it is possible that the response
rate would have been higher than observed had patients
been warned about the study in advance. On balance, we
believe that the response rate achieved is a relatively ac-
curate reflection of the popularity of the pedobaro-
graphic test, and reflects the likely response rate that
might be achieved in a full clinical trial.
The questions asked of participants regarding their
experience during data collection were not based on
any previously validated questionnaires, and largely
involved dichotomous (yes/no) responses (rather than
Likert scales). This was because we were unable to
find a validated questionnaire that addressed the rele-
vant topics.
Conclusions
The current feasibility study embedded pedobarographic
measurements into multiple unique diabetic foot clinic
settings in the New Zealand context, and observed a
high response rate and positive self-reported experience
from participants. With regards to disruption to normal
clinic time, the median time for pedobarographic testing
(including study introduction and consenting) was
25 min. All but one of the participants underwent pedo-
barographic testing after their normal clinical appoint-
ment. As part of our engagement with participants, we
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observed a high degree of lower-limb morbidity, includ-
ing current ulceration and chronic foot deformities. Des-
pite working with a high-risk population, there were no
adverse events in this study – an observation which is
in-keeping with the low-risk nature of the medical de-
vice(s) used during the study. In terms of application of
pedobarography as a clinical tool in the New Zealand
context, the current feasibility study leads us to believe
that there are two avenues that deserve further investiga-
tion: a) the use of pedobarography to inform the design
and effectiveness of offloading devices among high-risk
diabetic patients; and b) the use of pedobarography as a
means to increase offloading footwear and/or orthoses
compliance among high-risk diabetic patients. Both of
these objectives deserve further examination in New
Zealand via clinical trial.
Additional file
Additional file 1: Free-text responses from patients to the following post-
testing question: “What part of the information [from the pedobarography
results] did you find useful?”. (DOCX 17 kb)
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